CK20 and CK5/6 Immunohistochemical Staining of Urothelial Neoplasms: A Perspective

被引:12
作者
Akhtar, Mohammed [1 ]
Rashid, Sameera [1 ]
Gashir, Mohamed Ben [1 ]
Taha, Noheir Mostafa [1 ]
Al Bozom, Issam [1 ]
机构
[1] Hamad Med Corp, Dept Lab Med & Pathol, Doha, Qatar
关键词
CYTOKERATIN; 5/6; EXPRESSION; KERATINS; CANCER; CLASSIFICATION; SUBGROUPS; DIAGNOSIS; PATTERNS; MARKERS;
D O I
10.1155/2020/4920236
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cytokeratins belong to the family of intermediate filaments. They are expressed in a highly specific manner in epithelial cells where they play a crucial role in the integrity and mechanical stability of the cells. Several types of cytokeratins have been described in normal as well as neoplastic urothelium. In the case of urothelial neoplasms expression of CK20 and CK5/6 has been shown in several studies to have diagnostic and prognostic implications. Thus, low-grade urothelial carcinoma manifests CK expression limited to the umbrella cells, while high-grade tumors usually have an expression in the entire thickness of the urothelium except for the basal layer. CK5/6 expression on the other hand is expressed in the basal cells in all low-grade and some high-grade urothelial carcinomas. Diffuse CK20 staining accompanied by loss of CK5/6-positive basal layer is usually associated with aggressive clinical behavior. Double staining of the slides for these cytokeratins may facilitate proper interpretation and correlation.
引用
收藏
页数:9
相关论文
共 29 条
  • [1] Alonso A, 2009, HISTOL HISTOPATHOL, V24, P1425, DOI 10.14670/HH-24.1425
  • [2] Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors
    Alsheikh, A
    Mohamedali, Z
    Jones, E
    Masterson, J
    Gilks, CB
    [J]. MODERN PATHOLOGY, 2001, 14 (04) : 267 - 272
  • [3] Awasthi P., 2016, J ADV MED DENT SCI R, DOI [https://doi.org/10.21276/jamdsr.2016.4.4.30, DOI 10.21276/JAMDSR.2016.4.4.30]
  • [4] Baskin L., 2018, EMBRYOLOGY HUMAN GEN
  • [5] Cytokeratin 5/6 expression in benign and malignant breast lesions
    Bhalla, Amarpreet
    Manjari, Mridu
    Kahlon, S. K.
    Kumar, Parbodh
    Kalra, Nikita
    [J]. INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2010, 53 (04) : 676 - 680
  • [6] Expression of cytokeratin 5/6 in epithelial neoplasms: An immunohistochemical study of 509 cases
    Chu, PGG
    Weiss, LM
    [J]. MODERN PATHOLOGY, 2002, 15 (01) : 6 - 10
  • [7] Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016"
    Comperat, Eva M.
    Burger, Maximilian
    Gontero, Paolo
    Mostafid, A. Hugh
    Palou, Joan
    Roupret, Morgan
    van Rhijn, Bas W. G.
    Shariat, Shahrokh F.
    Sylvester, Richard J.
    Zigeuner, Richard
    Babjuk, Marko
    [J]. EUROPEAN UROLOGY FOCUS, 2019, 5 (03): : 457 - 466
  • [8] Changing patterns of keratin expression could be associated with functional maturation of the developing human bladder
    de la Rosette, J
    Smedts, F
    Schoots, C
    Hoek, H
    Laguna, P
    [J]. JOURNAL OF UROLOGY, 2002, 168 (02) : 709 - 717
  • [9] mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants
    Eckstein, Markus
    Wirtz, Ralph Markus
    Gross-Weege, Matthias
    Breyer, Johannes
    Otto, Wolfgang
    Stoehr, Robert
    Sikic, Danijel
    Keck, Bastian
    Eidt, Sebastian
    Burger, Maximilian
    Bolenz, Christian
    Nitschke, Katja
    Porubsky, Stefan
    Hartmann, Arndt
    Erben, Philipp
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [10] Epstein JI, 2014, AM J SURG PATHOL, V38, pE6, DOI 10.1097/PAS.0000000000000238